UK researchers are complaining that ethical standards and adminstrative hurdles introduced after a scandal involving a National Health Service hospital, have damaged medical research in the country.
Jenny Hewison, a clinical researcher at Leeds University, told the UK's Guardian newspaper that it is "a disaster and it is absolutely not in the public interest." Dr Hewison and Andy Haines, a colleague at the London School of Hygiene and Tropical Medicine, have written to the British Medical Journal to raise concerns about the unintended effects of new regulations.
800 infants' body parts taken
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze